Drug Information

Drug General Information
Drug ID
D0M2GI
Former ID
DIB016636
Drug Name
CI-1002
Synonyms
PD-142676
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Terminated [533784]
Company
Parke-Davis & Co
Canonical SMILES
N1=C2N(Cc3c1cc(cc3Cl)Cl)CCCCC2
CAS Number
CAS 149028-28-4
Target and Pathway
Target(s) Acetylcholinesterase Target Info Modulator [533784]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 533784PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonist. Mol Neurobiol. 1994 Aug-Dec;9(1-3):93-106.
Ref 533784PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonist. Mol Neurobiol. 1994 Aug-Dec;9(1-3):93-106.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.